ISIN | LU1033754018 |
---|---|
Valor Number | 23712967 |
Bloomberg Global ID | |
Fund Name | PROTEA - Sectoral Emerging Markets Healthcare Fund IF USD |
Fund Provider |
Sectoral Asset Management Inc
1010 Sherbrooke St. West, Suite 1610 QC H3A 2R7 Montreal Canada Phone: +1 514 849 8777 E-Mail: BusinessDevelopment@sectoral.com |
Fund Provider | Sectoral Asset Management Inc |
Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | This Sub-Fund aims to achieve capital growth in USD. While respecting the principle of risk diversification, the Sub-Fund’s net assets are primarily invested in equities, equitylike transferable securities, participation certificates etc. issued by small, mid and large cap companies which are based in an emerging market and/or conduct the majority of their business in an emerging market and are mainly active in the healthcare sector and depositary receipts, such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs), referring to such securities. |
Peculiarities |
Current Price * | 10.22 USD | 04.09.2024 |
---|---|---|
Previous Price * | 10.22 USD | 03.09.2024 |
52 Week High * | 11.44 USD | 15.11.2023 |
52 Week Low * | 9.11 USD | 18.04.2024 |
NAV * | 10.22 USD | 04.09.2024 |
Issue Price * | 10.22 USD | 04.09.2024 |
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 4,208,851 | |
Unit/Share Assets *** | 3,431,731 | |
Trading Information SIX |
YTD Performance | -6.67% |
29.12.2023 - 04.09.2024
29.12.2023 04.09.2024 |
---|---|---|
YTD Performance (in CHF) | -6.11% |
29.12.2023 - 04.09.2024
29.12.2023 04.09.2024 |
1 month | +3.86% |
05.08.2024 - 04.09.2024
05.08.2024 04.09.2024 |
3 months | +5.04% |
04.06.2024 - 04.09.2024
04.06.2024 04.09.2024 |
6 months | +1.39% |
04.03.2024 - 04.09.2024
04.03.2024 04.09.2024 |
1 year | -5.98% |
04.09.2023 - 04.09.2024
04.09.2023 04.09.2024 |
2 years | -10.35% |
05.09.2022 - 04.09.2024
05.09.2022 04.09.2024 |
3 years | -46.91% |
06.09.2021 - 04.09.2024
06.09.2021 04.09.2024 |
5 years | +2.61% |
04.09.2019 - 04.09.2024
04.09.2019 04.09.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 04.09.2024 |
Celltrion Inc | 6.25% | |
---|---|---|
Samsung BioLogics Co Ltd | 5.66% | |
Apollo Hospitals Enterprise Ltd | 5.48% | |
Dr Reddy's Laboratories Ltd ADR | 5.00% | |
Sun Pharmaceuticals Industries Ltd | 4.84% | |
BeiGene Ltd ADR | 4.32% | |
WuXi Biologics (Cayman) Inc | 4.29% | |
Rede d or Sao Luiz SA Ordinary Shares | 4.24% | |
Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt | 3.90% | |
Cipla Ltd | 3.59% | |
Last data update | 31.12.2023 |
TER | 1.70% |
---|---|
TER date | 30.06.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.10% |
Ongoing Charges *** | 1.58% |
SRRI ***
|
|
SRRI date *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |